14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $137.78 $156.84 Wednesday, 24th Apr 2024 ASND stock ended at $143.18. This is 1.14% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.56% from a day low at $141.06 to a day high of $144.68.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Feb 17, 2021 $160.52 $169.00 $158.41 $168.19 186 727
Feb 16, 2021 $161.97 $163.98 $159.14 $160.65 261 507
Feb 12, 2021 $149.18 $160.67 $147.86 $160.67 351 551
Feb 11, 2021 $155.00 $155.00 $147.98 $149.17 221 480
Feb 10, 2021 $154.60 $156.72 $151.36 $154.13 180 805
Feb 09, 2021 $154.63 $155.87 $153.29 $154.08 157 005
Feb 08, 2021 $153.00 $156.77 $152.21 $153.93 183 665
Feb 05, 2021 $152.61 $154.55 $151.01 $152.72 266 570
Feb 04, 2021 $150.31 $151.46 $147.84 $150.88 200 436
Feb 03, 2021 $151.16 $153.04 $149.86 $149.98 93 660
Feb 02, 2021 $150.00 $151.87 $145.80 $151.16 176 690
Feb 01, 2021 $151.16 $152.00 $147.34 $149.38 235 671
Jan 29, 2021 $156.28 $158.36 $150.09 $150.15 169 573
Jan 28, 2021 $151.89 $160.21 $151.74 $155.39 168 146
Jan 27, 2021 $155.56 $155.56 $148.35 $152.00 288 528
Jan 26, 2021 $160.36 $161.00 $153.72 $155.72 321 549
Jan 25, 2021 $161.00 $162.21 $157.05 $158.89 207 729
Jan 22, 2021 $154.24 $161.52 $153.23 $160.66 198 080
Jan 21, 2021 $157.43 $157.43 $153.38 $154.86 111 562
Jan 20, 2021 $159.51 $160.75 $153.94 $156.45 137 195
Jan 19, 2021 $161.77 $163.54 $157.41 $158.28 216 393
Jan 15, 2021 $160.82 $162.63 $152.47 $157.93 359 065
Jan 14, 2021 $165.50 $166.62 $161.66 $162.01 151 295
Jan 13, 2021 $174.86 $175.10 $165.37 $165.50 108 530
Jan 12, 2021 $172.90 $177.61 $172.21 $173.21 143 191
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT